Jaguar Health (JAGX) Interest Coverage Ratio Growth (3y) (2017 - 2025)
Jaguar Health (JAGX) Interest Coverage Ratio Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-307.02% |
| Sep 30, 2025 |
-593.07% |
| Jun 30, 2025 |
495.28% |
| Mar 31, 2025 |
295.85% |
| Dec 31, 2024 |
165.29% |
| Sep 30, 2024 |
127.51% |
| Jun 30, 2024 |
138.47% |
| Mar 31, 2024 |
85.47% |
| Dec 31, 2023 |
-108.32% |
| Sep 30, 2023 |
-23.85% |
| Jun 30, 2023 |
48.96% |
| Dec 31, 2022 |
58.53% |
| Sep 30, 2022 |
10.01% |
| Jun 30, 2022 |
4.19% |
| Mar 31, 2022 |
35.73% |
| Dec 31, 2021 |
45.41% |
| Sep 30, 2021 |
14.98% |
| Jun 30, 2021 |
16.62% |
| Mar 31, 2021 |
-701.32% |
| Dec 31, 2020 |
59.46% |
